Literature DB >> 22042691

Biocompatibility and biodegradation of polycaprolactone-sebacic acid blended gels.

Christiane L Salgado1, Elisabete M S Sanchez, Cecília A C Zavaglia, Pedro L Granja.   

Abstract

Tissue engineering aims at creating biological body parts as an alternative for transplanting tissues and organs. A current new approach for such materials consists in injectable biodegradable polymers. Their major advantages are the ability to fill-in defects, easy incorporation of therapeutic agents or cells, and the possibility of minimal invasive surgical procedures. Polycaprolactone (PCL) is a promising biodegradable and elastic biomaterial, with the drawback of low-degradation kinetics in vivo. In this work a biodegradable injectable gel of PCL blended with sebacic acid (SA) was prepared, to improve the degradation rate of the biomaterial. SA is known for its high degradation rate, although in high concentrations it could originate a pH decrease and thus disturb the biocompatibility of PCL. Degradation tests on phosphate buffered saline were carried out using 5% of SA on the blend and the biomaterial stability was evaluated after degradation using differential scanning calorimetry, dynamical mechanical analysis, and scanning electronic microscopy. After degradation the elastic properties of the blend decreased and the material became more crystalline and stiffer, although at a lower extent when compared with pure PCL. The blend also degraded faster with a loss of the crystalline phase on the beginning (30 days), although its thermal and mechanical properties remained comparable with those of the pure material, thus showing that it achieved the intended objectives. After cell assays the PCL-SA gel was shown to be cytocompatible and capable of maintaining high cell viability (over 90%).
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042691     DOI: 10.1002/jbm.a.33272

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Bilayer oxidized regenerated cellulose/poly ε-caprolactone knitted fabric-reinforced composite for use as an artificial dural substitute.

Authors:  Jintamai Suwanprateeb; Ticomporn Luangwattanawilai; Thunyanun Theeranattapong; Waraporn Suvannapruk; Sorayouth Chumnanvej; Warinkarn Hemstapat
Journal:  J Mater Sci Mater Med       Date:  2016-06-09       Impact factor: 3.896

2.  Electrospun Carbon Nanotube-Based Scaffolds Exhibit High Conductivity and Cytocompatibility for Tissue Engineering Applications.

Authors:  Taylor C Suh; Jack Twiddy; Nasif Mahmood; Kiran M Ali; Mostakima M Lubna; Philip D Bradford; Michael A Daniele; Jessica M Gluck
Journal:  ACS Omega       Date:  2022-06-02

3.  Porous poly(ε-caprolactone) scaffolds for retinal pigment epithelium transplantation.

Authors:  Kevin J McHugh; Sarah L Tao; Magali Saint-Geniez
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-25       Impact factor: 4.799

Review 4.  Novel Approaches Guiding the Future of Spinal Biologics for Bone Regeneration.

Authors:  Eileen N Phan; Wellington K Hsu
Journal:  Curr Rev Musculoskelet Med       Date:  2022-04-18

5.  Bone Regeneration after Treatment with Covering Materials Composed of Flax Fibers and Biodegradable Plastics: A Histological Study in Rats.

Authors:  Tomasz Gredes; Franziska Kunath; Tomasz Gedrange; Christiane Kunert-Keil
Journal:  Biomed Res Int       Date:  2016-08-11       Impact factor: 3.411

6.  Electrospun Fibers and Sorbents as a Possible Basis for Effective Composite Wound Dressings.

Authors:  Alan Saúl Álvarez-Suárez; Syed G Dastager; Nina Bogdanchikova; Daniel Grande; Alexey Pestryakov; Juan Carlos García-Ramos; Graciela Lizeth Pérez-González; Karla Juárez-Moreno; Yanis Toledano-Magaña; Elena Smolentseva; Juan Antonio Paz-González; Tatiana Popova; Lyubov Rachkovskaya; Vadim Nimaev; Anastasia Kotlyarova; Maksim Korolev; Andrey Letyagin; Luis Jesús Villarreal-Gómez
Journal:  Micromachines (Basel)       Date:  2020-04-22       Impact factor: 2.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.